tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Jazz Pharmaceuticals says EC grants marketing authorization for Ziihera

Jazz Pharmaceuticals (JAZZ) announced that the European Commission has granted conditional marketing authorization for Ziihera, a dual human epidermal growth factor receptor 2-targeted bispecific antibody, as monotherapy for the treatment of adults with unresectable locally advanced or metastatic HER2-positive biliary tract cancer previously treated with at least one prior line of systemic therapy.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1